当前位置: X-MOL 学术Nat. Rev. Drug. Disc. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
BMS buys Turning Point Therapeutics and its kinase inhibitors for $4.1 billion
Nature Reviews Drug Discovery ( IF 120.1 ) Pub Date : 2022-06-09 , DOI: 10.1038/d41573-022-00104-3
Asher Mullard

Discover the world’s best science and medicine | Nature.com

中文翻译:

BMS 以 41 亿美元收购 Turning Point Therapeutics 及其激酶抑制剂

发现世界上最好的科学和医学| 自然网
更新日期:2022-06-09
down
wechat
bug